Started the partner project and started 4.27 "New Culture Construction"; Kangda relocated to Hangzhou Bay Biotechnology Park; started the research and development of 800-speed biochemical instrument

Huayan company landed in Haining and started the chemiluminescence product line;

Delisting from the New Third Board, the company is reorganized, and the layout of the Belt and Road Initiative; Hangzhou Emerox Medical Technology Co., Ltd. was awarded "National High-tech Enterprise";

Multi-brand operation, the establishment of an Anhui subsidiary, the acquisition of Luohe Jianshi Ledger; the company's immunohistochemical stainer products won the title of "Made in Zhejiang";

In 2017, the automatic immunohistochemical staining instrument was launched; the new model of Internet + medical treatment was explored

The company was identified as "Provincial Medical Device Manufacturing Enterprise Quality Credit Integrity Grade Enterprise", Municipal Strategic Emerging Industry Cultivation Enterprise, and "Top 120 Industrial Enterprises in the District"; the re-identification of "High-tech Enterprise" was successfully passed; in June of the same year, it participated in the international The reference laboratory proficiency test 2015-RELA, with excellent results.

The feces pretreatment instrument (FAS-Isa) was successfully developed and officially put into the market; the company was listed as "the first batch of key cultivation enterprises in emerging industries in Xiaoshan District", and the company's enterprise center was identified as "the sixteenth batch of Xiaoshan District-level enterprise technology" Center"; the R&D center was identified as "Hangzhou High-tech R&D Center"; in October of the same year, the company successfully landed on the National Share Transfer System, stock code 833929.

It was restructured and established Zhejiang Century Kangda Medical Technology Co., Ltd., which was registered in Hangzhou Market Supervision and Administration Bureau in November 2014.

Signed a full-automatic blood bank system agency agreement with IMMUCOR. In the same year, the Hangzhou company passed the ISO13485 quality management system certification and product CE certification, and was recognized as a "national high-tech enterprise". 63 clinical biochemical reagent products were approved for IVD product registration, and successfully listed on the innovation board of Zhejiang Equity Exchange Center with enterprise code 851002.

Cooperated with Korea Cell&Tech Co.,Ltd. to develop and produce liquid-based cell system (TCT) series products.

"Zhejiang University of Technology Kangda Medical Instrument Research Institute" was established; the first-generation automatic immunohistochemical staining instrument was approved for registration; Bolton was recognized as "Hangzhou Science and Technology Small and Medium-sized Enterprises"; the company began to develop 29 kinds of human genes Genotyping diagnostic gene sequencing reagent.

The 100,000-level dust-free purification workshop of in vitro diagnostic reagents in the Hangzhou production base has successfully passed the acceptance inspection; the company has been awarded the honorary titles of "China National Health and Poverty Alleviation Project Caring Enterprise" and "National Quality Credit AAA Enterprise".

The "Kangda-Bodun Science and Technology Park" covering an area of 40 acres was completed; more than 20 new products such as specific protein detection received the national in vitro diagnostic reagent registration approval; the company's second-generation "automatic immunohistochemical staining instrument" started research and development; The Technical Research Institute was established.

As the implementation unit of the "Eleventh Five-Year" support project of the Ministry of Science and Technology of the People's Republic of China, it is responsible for the research and development, promotion and application of portable urine analyzers.

The company's products have passed the EU CE certification, opening the European market; it is the first time to participate in international medical exhibitions such as MEDICA in Germany and AACC in the United States.

Kangda Medical has formally signed agency agreements with Toshiba Medical and Siemens Diagnostics; more than 40 clinical biochemical reagents and urinalysis products of the Beijing company have been approved by the State Food and Drug Administration, and participated in the inter-laboratory quality assessment of the National Ministry of Health Clinical Inspection Center and achieved excellent results.

Kangda Medical acquired Beijing Ordo Steike Medical Technology Co., Ltd." and established Beijing Kangda Taike Medical Technology Co., Ltd.; in the same year, the Beijing company passed the IS09001/13485 quality management system certification and "high-tech enterprise" certification.

The "Automatic Urinary Sediment Analyzer" developed by the company has won the Technology Innovation Fund Project of the Ministry of Science and Technology of Science and Technology Small and Medium-sized Enterprises.

The company began to develop the first generation of "Automatic Histochemical Staining Instrument", and won the key project of Hangzhou Pharmaceutical Industry Development Fund.

"CONDOR" became the registered trademark of Kangda Medical. Kangda production base settled in Xiaoshan

Kangda Medical's predecessor, "Hangzhou Kangda Health Care Application Co., Ltd." was registered and established, and became the Zhejiang Province agent of the American Beckman Company.